DECIPHERA PHARMACEUTICALS IN's ticker is and the CUSIP is 24344T901. A total of 4 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | -93.1% | 200 | -90.5% | 0.00% | – |
| Q2 2023 | $29 | -29.3% | 2,100 | -22.2% | 0.00% | – |
| Q1 2023 | $41 | -85.4% | 2,700 | -84.2% | 0.00% | – |
| Q4 2022 | $280 | -99.9% | 17,100 | -7.6% | 0.00% | – |
| Q3 2022 | $342,000 | -75.7% | 18,500 | -82.7% | 0.00% | -100.0% |
| Q2 2022 | $1,409,000 | +70.8% | 107,200 | +20.4% | 0.00% | 0.0% |
| Q1 2022 | $825,000 | -12.3% | 89,000 | -7.7% | 0.00% | 0.0% |
| Q4 2021 | $941,000 | +148.9% | 96,400 | +845.1% | 0.00% | – |
| Q3 2021 | $378,000 | +1.3% | 10,200 | 0.0% | 0.00% | – |
| Q2 2021 | $373,000 | +60.1% | 10,200 | +19515.4% | 0.00% | – |
| Q1 2021 | $233,000 | +13.7% | 52 | +44.4% | 0.00% | – |
| Q4 2020 | $205,000 | 0.0% | 36 | -10.0% | 0.00% | – |
| Q3 2020 | $205,000 | -25.2% | 40 | -13.0% | 0.00% | – |
| Q2 2020 | $274,000 | +878.6% | 46 | +557.1% | 0.00% | – |
| Q1 2020 | $28,000 | -75.0% | 7 | -61.1% | 0.00% | – |
| Q4 2019 | $112,000 | +57.7% | 18 | -14.3% | 0.00% | – |
| Q3 2019 | $71,000 | +136.7% | 21 | +162.5% | 0.00% | – |
| Q3 2018 | $30,000 | – | 8 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 99,700 | $3,650,000 | 0.11% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,900 | $70,000 | 0.00% |
| SIMPLEX TRADING, LLC | 10,200 | $373,000 | 0.00% |
| JPMORGAN CHASE & CO | 25,000 | $915,000 | 0.00% |